Non-Current Assets
PP&E (Net)
Gilead Sciences PP&E (Net) increased by 0.6% to $5.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.0%, from $5.42B to $5.64B. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows an upward trend with a 2.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase indicates capital investment in production capacity, while a decrease may signal divestment or high depreciation rates.
Detailed definition
This represents the net book value of long-term physical assets such as manufacturing facilities, laboratories, and offi...
Peer comparison
Standard across all industries; high for manufacturing-heavy firms and lower for pure-play R&D firms.
Metric ID:
property_plant_equipment_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.00B | $5.04B | $5.12B | $5.25B | $5.30B | $5.35B | $5.48B | $5.48B | $5.54B | $5.57B | $5.32B | $5.32B | $5.35B | $5.39B | $5.41B | $5.42B | $5.46B | $5.50B | $5.61B | $5.64B |
| QoQ Change | — | +0.8% | +1.7% | +2.6% | +0.9% | +0.9% | +2.4% | +0.1% | +1.1% | +0.6% | -4.6% | +0.1% | +0.5% | +0.8% | +0.4% | +0.1% | +0.7% | +0.8% | +1.9% | +0.6% |
| YoY Change | — | — | — | — | +6.1% | +6.2% | +6.9% | +4.3% | +4.5% | +4.2% | -2.9% | -2.9% | -3.5% | -3.2% | +1.8% | +1.9% | +2.1% | +2.0% | +3.5% | +4.0% |
Range$5.00B – $5.64B
CAGR+2.6%
Avg YoY Growth+2.2%
Median YoY Growth+2.8%
Current Streak9 quarters growth
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's pp&e (net)?
- Gilead Sciences (GILD) reported pp&e (net) of $5.64B in Q1 2026.
- How has Gilead Sciences's pp&e (net) changed year-over-year?
- Gilead Sciences's pp&e (net) increased by 4.0% year-over-year, from $5.42B to $5.64B.
- What is the long-term trend for Gilead Sciences's pp&e (net)?
- Over 5 years (2020 to 2025), Gilead Sciences's pp&e (net) has grown at a 2.4% compound annual growth rate (CAGR), from $4.97B to $5.61B.
- What does pp&e (net) mean?
- The value of the company's physical buildings and equipment, minus wear and tear.